Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
The challenges of peripheral bone density testing: which patients need additional central density skeletal measurements?.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry

Miller PD, Bonnick SL, Johnston CC, Kleerekoper M, Lindsay RL, Sherwood LM, Siris ES.
PMID: 15304891
J Clin Densitom. 1998;1(3):211-7. doi: 10.1385/jcd:1:3:211.

Lower cost, portable, peripheral bone mass measurement devices are being increasingly utilized for widespread bone mass testing. These devices are being placed in traditional medical settings as well as nontraditional settings, such as pharmacies and grocery stores. Increased bone...

Cite
Miller PD, Bonnick SL, Johnston CC, et al. The challenges of peripheral bone density testing: which patients need additional central density skeletal measurements?. J Clin Densitom. 1998;1(3):211-7doi: 10.1385/jcd:1:3:211.
Miller, P. D., Bonnick, S. L., Johnston, C. C., Kleerekoper, M., Lindsay, R. L., Sherwood, L. M., & Siris, E. S. (1998). The challenges of peripheral bone density testing: which patients need additional central density skeletal measurements?. Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 1(3), 211-7. https://doi.org/10.1385/jcd:1:3:211
Miller, P D, et al. "The challenges of peripheral bone density testing: which patients need additional central density skeletal measurements?." Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry vol. 1,3 (1998): 211-7. doi: https://doi.org/10.1385/jcd:1:3:211
Miller PD, Bonnick SL, Johnston CC, Kleerekoper M, Lindsay RL, Sherwood LM, Siris ES. The challenges of peripheral bone density testing: which patients need additional central density skeletal measurements?. J Clin Densitom. 1998;1(3):211-7. doi: 10.1385/jcd:1:3:211. PMID: 15304891.
Copy Download .nbib Format: NLM
Postmenopausal osteoporosis: an update on current and future therapeutic options.

Expert review of endocrinology & metabolism

Camacho PM, Armamento-Villareal R, Kleerekoper M.
PMID: 30743750
Expert Rev Endocrinol Metab. 2007 Jan;2(1):79-90. doi: 10.1586/17446651.2.1.79.

Recent advances in osteoporosis have dramatically changed the management and treatment of this disease. This article reviews the safety and efficacy of US FDA-approved drugs for prevention and treatment of postmenopausal osteoporosis, as well as studies on combination, sequential...

Cite
Camacho PM, Armamento-Villareal R, Kleerekoper M. Postmenopausal osteoporosis: an update on current and future therapeutic options. Expert Rev Endocrinol Metab. 2007;2(1):79-90doi: 10.1586/17446651.2.1.79.
Camacho, P. M., Armamento-Villareal, R., & Kleerekoper, M. (2007). Postmenopausal osteoporosis: an update on current and future therapeutic options. Expert review of endocrinology & metabolism, 2(1), 79-90. https://doi.org/10.1586/17446651.2.1.79
Camacho, Pauline M, et al. "Postmenopausal osteoporosis: an update on current and future therapeutic options." Expert review of endocrinology & metabolism vol. 2,1 (2007): 79-90. doi: https://doi.org/10.1586/17446651.2.1.79
Camacho PM, Armamento-Villareal R, Kleerekoper M. Postmenopausal osteoporosis: an update on current and future therapeutic options. Expert Rev Endocrinol Metab. 2007 Jan;2(1):79-90. doi: 10.1586/17446651.2.1.79. PMID: 30743750.
Copy Download .nbib Format: NLM
New and improved FRAX.

Expert review of endocrinology & metabolism

Kleerekoper M.
PMID: 30764040
Expert Rev Endocrinol Metab. 2010 Mar;5(2):165-167. doi: 10.1586/eem.10.8.

No abstract available.

Cite
Kleerekoper M. New and improved FRAX. Expert Rev Endocrinol Metab. 2010;5(2):165-167doi: 10.1586/eem.10.8.
Kleerekoper, M. (2010). New and improved FRAX. Expert review of endocrinology & metabolism, 5(2), 165-167. https://doi.org/10.1586/eem.10.8
Kleerekoper, Michael. "New and improved FRAX." Expert review of endocrinology & metabolism vol. 5,2 (2010): 165-167. doi: https://doi.org/10.1586/eem.10.8
Kleerekoper M. New and improved FRAX. Expert Rev Endocrinol Metab. 2010 Mar;5(2):165-167. doi: 10.1586/eem.10.8. PMID: 30764040.
Copy Download .nbib Format: NLM
Secondary osteoporosis: endocrine and metabolic causes of bone mass deterioration.

Journal of osteoporosis

Miazgowski T, Kleerekoper M, Felsenberg D, Stěpán JJ, Szulc P.
PMID: 22523717
J Osteoporos. 2012;2012:907214. doi: 10.1155/2012/907214. Epub 2012 Feb 23.

No abstract available.

Cite
Miazgowski T, Kleerekoper M, Felsenberg D, et al. Secondary osteoporosis: endocrine and metabolic causes of bone mass deterioration. J Osteoporos. 2012;2012:907214doi: 10.1155/2012/907214.
Miazgowski, T., Kleerekoper, M., Felsenberg, D., Stěpán, J. J., & Szulc, P. (2012). Secondary osteoporosis: endocrine and metabolic causes of bone mass deterioration. Journal of osteoporosis, 2012907214. https://doi.org/10.1155/2012/907214
Miazgowski, Tomasz, et al. "Secondary osteoporosis: endocrine and metabolic causes of bone mass deterioration." Journal of osteoporosis vol. 2012 (2012): 907214. doi: https://doi.org/10.1155/2012/907214
Miazgowski T, Kleerekoper M, Felsenberg D, Stěpán JJ, Szulc P. Secondary osteoporosis: endocrine and metabolic causes of bone mass deterioration. J Osteoporos. 2012;2012:907214. doi: 10.1155/2012/907214. Epub 2012 Feb 23. PMID: 22523717; PMCID: PMC3317090.
Copy Download .nbib Format: NLM
How common are functional incidentalomas of the parathyroid gland?.

Nature clinical practice. Endocrinology & metabolism

Koenig K, Kleerekoper M.
PMID: 16932308
Nat Clin Pract Endocrinol Metab. 2006 Jun;2(6):316-7. doi: 10.1038/ncpendmet0193.

No abstract available.

Cite
Koenig K, Kleerekoper M. How common are functional incidentalomas of the parathyroid gland?. Nat Clin Pract Endocrinol Metab. 2006;2(6):316-7doi: 10.1038/ncpendmet0193.
Koenig, K., & Kleerekoper, M. (2006). How common are functional incidentalomas of the parathyroid gland?. Nature clinical practice. Endocrinology & metabolism, 2(6), 316-7. https://doi.org/10.1038/ncpendmet0193
Koenig, Karen, and Kleerekoper, Michael. "How common are functional incidentalomas of the parathyroid gland?." Nature clinical practice. Endocrinology & metabolism vol. 2,6 (2006): 316-7. doi: https://doi.org/10.1038/ncpendmet0193
Koenig K, Kleerekoper M. How common are functional incidentalomas of the parathyroid gland?. Nat Clin Pract Endocrinol Metab. 2006 Jun;2(6):316-7. doi: 10.1038/ncpendmet0193. PMID: 16932308.
Copy Download .nbib Format: NLM
Correction to: Assessment of thermally comfortable urban spaces in Amsterdam during hot summer days.

International journal of biometeorology

Klok L, Rood N, Kluck J, Kleerekoper L.
PMID: 31686195
Int J Biometeorol. 2020 Feb;64(2):303. doi: 10.1007/s00484-019-01818-7.

The article was published without special issue designation resulting in regular issue compilation. The author group and publisher regret the error and ask the article be considered for Special Issue: Subjective approaches to thermal perception.

Cite
Klok L, Rood N, Kluck J, et al. Correction to: Assessment of thermally comfortable urban spaces in Amsterdam during hot summer days. Int J Biometeorol. 2020;64(2):303doi: 10.1007/s00484-019-01818-7.
Klok, L., Rood, N., Kluck, J., & Kleerekoper, L. (2020). Correction to: Assessment of thermally comfortable urban spaces in Amsterdam during hot summer days. International journal of biometeorology, 64(2), 303. https://doi.org/10.1007/s00484-019-01818-7
Klok, Lisette, et al. "Correction to: Assessment of thermally comfortable urban spaces in Amsterdam during hot summer days." International journal of biometeorology vol. 64,2 (2020): 303. doi: https://doi.org/10.1007/s00484-019-01818-7
Klok L, Rood N, Kluck J, Kleerekoper L. Correction to: Assessment of thermally comfortable urban spaces in Amsterdam during hot summer days. Int J Biometeorol. 2020 Feb;64(2):303. doi: 10.1007/s00484-019-01818-7. PMID: 31686195.
Copy Download .nbib Format: NLM
Optical Coherence Tomography Angiography (OCTA) in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.

Frontiers in neurology

Kleerekooper I, Houston S, Dubis AM, Trip SA, Petzold A.
PMID: 33362705
Front Neurol. 2020 Dec 10;11:604049. doi: 10.3389/fneur.2020.604049. eCollection 2020.

Vascular changes are increasingly recognized as important factors in the pathophysiology of neuroinflammatory disease, especially in multiple sclerosis (MS). The relatively novel technology of optical coherence tomography angiography (OCTA) images the retinal and choroidal vasculature non-invasively and in a...

Cite
Kleerekooper I, Houston S, Dubis AM, et al. Optical Coherence Tomography Angiography (OCTA) in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. Front Neurol. 2020;11:604049doi: 10.3389/fneur.2020.604049.
Kleerekooper, I., Houston, S., Dubis, A. M., Trip, S. A., & Petzold, A. (2020). Optical Coherence Tomography Angiography (OCTA) in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. Frontiers in neurology, 11604049. https://doi.org/10.3389/fneur.2020.604049
Kleerekooper, Iris, et al. "Optical Coherence Tomography Angiography (OCTA) in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder." Frontiers in neurology vol. 11 (2020): 604049. doi: https://doi.org/10.3389/fneur.2020.604049
Kleerekooper I, Houston S, Dubis AM, Trip SA, Petzold A. Optical Coherence Tomography Angiography (OCTA) in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. Front Neurol. 2020 Dec 10;11:604049. doi: 10.3389/fneur.2020.604049. eCollection 2020. PMID: 33362705; PMCID: PMC7758345.
Copy Download .nbib Format: NLM
Equation-Method for correcting clipping errors in OFDM signals.

SpringerPlus

Bibi N, Kleerekoper A, Muhammad N, Cheetham B.
PMID: 27386375
Springerplus. 2016 Jun 30;5(1):931. doi: 10.1186/s40064-016-2413-0. eCollection 2016.

Orthogonal frequency division multiplexing (OFDM) is the digital modulation technique used by 4G and many other wireless communication systems. OFDM signals have significant amplitude fluctuations resulting in high peak to average power ratios which can make an OFDM transmitter...

Cite
Bibi N, Kleerekoper A, Muhammad N, et al. Equation-Method for correcting clipping errors in OFDM signals. Springerplus. 2016;5(1):931doi: 10.1186/s40064-016-2413-0.
Bibi, N., Kleerekoper, A., Muhammad, N., & Cheetham, B. (2016). Equation-Method for correcting clipping errors in OFDM signals. SpringerPlus, 5(1), 931. https://doi.org/10.1186/s40064-016-2413-0
Bibi, Nargis, et al. "Equation-Method for correcting clipping errors in OFDM signals." SpringerPlus vol. 5,1 (2016): 931. doi: https://doi.org/10.1186/s40064-016-2413-0
Bibi N, Kleerekoper A, Muhammad N, Cheetham B. Equation-Method for correcting clipping errors in OFDM signals. Springerplus. 2016 Jun 30;5(1):931. doi: 10.1186/s40064-016-2413-0. eCollection 2016. PMID: 27386375; PMCID: PMC4929106.
Copy Download .nbib Format: NLM
Biochemical studies in the evaluation and management of osteoporosis: current status and future prospects.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Kleerekoper M, Edelson GW.
PMID: 15251558
Endocr Pract. 1996 Jan-Feb;2(1):13-9. doi: 10.4158/EP.2.1.13.

OBJECTIVE: To examine the current status of biochemical markers of bone remodeling and to offer a perspective on their future clinical applications.METHODS: We provide a comprehensive overview of the bone remodeling cycle, the hormonal control of bone remodeling, the...

Cite
Kleerekoper M, Edelson GW. Biochemical studies in the evaluation and management of osteoporosis: current status and future prospects. Endocr Pract. 1996;2(1):13-9doi: 10.4158/EP.2.1.13.
Kleerekoper, M., & Edelson, G. W. (1996). Biochemical studies in the evaluation and management of osteoporosis: current status and future prospects. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2(1), 13-9. https://doi.org/10.4158/EP.2.1.13
Kleerekoper, M, and Edelson, G W. "Biochemical studies in the evaluation and management of osteoporosis: current status and future prospects." Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists vol. 2,1 (1996): 13-9. doi: https://doi.org/10.4158/EP.2.1.13
Kleerekoper M, Edelson GW. Biochemical studies in the evaluation and management of osteoporosis: current status and future prospects. Endocr Pract. 1996 Jan-Feb;2(1):13-9. doi: 10.4158/EP.2.1.13. PMID: 15251558.
Copy Download .nbib Format: NLM
Prevalence of osteoporosis in women referred for bone density testing: utility of multiple skeletal sites.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry

Nelson DA, Molloy R, Kleerekoper M.
PMID: 15304907
J Clin Densitom. 1998;1(1):5-11. doi: 10.1385/jcd:1:1:5.

The objective of this study was to determine retrospectively the prevalence of osteoporosis in a referral population and to compare the effectiveness of measuring multiple skeletal sites for identifying osteoporosis. Although osteoporosis is considered to be a major public...

Cite
Nelson DA, Molloy R, Kleerekoper M. Prevalence of osteoporosis in women referred for bone density testing: utility of multiple skeletal sites. J Clin Densitom. 1998;1(1):5-11doi: 10.1385/jcd:1:1:5.
Nelson, D. A., Molloy, R., & Kleerekoper, M. (1998). Prevalence of osteoporosis in women referred for bone density testing: utility of multiple skeletal sites. Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 1(1), 5-11. https://doi.org/10.1385/jcd:1:1:5
Nelson, D A, et al. "Prevalence of osteoporosis in women referred for bone density testing: utility of multiple skeletal sites." Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry vol. 1,1 (1998): 5-11. doi: https://doi.org/10.1385/jcd:1:1:5
Nelson DA, Molloy R, Kleerekoper M. Prevalence of osteoporosis in women referred for bone density testing: utility of multiple skeletal sites. J Clin Densitom. 1998;1(1):5-11. doi: 10.1385/jcd:1:1:5. PMID: 15304907.
Copy Download .nbib Format: NLM
Disease activity following pregnancy-related discontinuation of natalizumab in MS.

Neurology(R) neuroimmunology & neuroinflammation

Kleerekooper I, van Kempen ZLE, Leurs CE, Dekker I, Rispens T, Lissenberg-Witte BI, van Munster CEP, de Jong BA, van Oosten BW, Uitdehaag BMJ, Wattjes MP, Killestein J.
PMID: 29379823
Neurol Neuroimmunol Neuroinflamm. 2017 Dec 05;5(1):e424. doi: 10.1212/NXI.0000000000000424. eCollection 2018 Jan.

OBJECTIVE: To investigate disease activity and disability progression following pregnancy-related discontinuation of natalizumab (NTZ) in patients with relapsing-remitting MS.METHODS: A retrospective cohort study of clinical and radiologic data in patients who discontinued NTZ for pregnancy-related reasons.RESULTS: Twenty-two pregnancy-related NTZ...

Cite
Kleerekooper I, van Kempen ZLE, Leurs CE, et al. Disease activity following pregnancy-related discontinuation of natalizumab in MS. Neurol Neuroimmunol Neuroinflamm. 2017;5(1):e424doi: 10.1212/NXI.0000000000000424.
Kleerekooper, I., van Kempen, Z. L. E., Leurs, C. E., Dekker, I., Rispens, T., Lissenberg-Witte, B. I., van Munster, C. E. P., de Jong, B. A., van Oosten, B. W., Uitdehaag, B. M. J., Wattjes, M. P., & Killestein, J. (2018). Disease activity following pregnancy-related discontinuation of natalizumab in MS. Neurology(R) neuroimmunology & neuroinflammation, 5(1), e424. https://doi.org/10.1212/NXI.0000000000000424
Kleerekooper, Iris, et al. "Disease activity following pregnancy-related discontinuation of natalizumab in MS." Neurology(R) neuroimmunology & neuroinflammation vol. 5,1 (2018): e424. doi: https://doi.org/10.1212/NXI.0000000000000424
Kleerekooper I, van Kempen ZLE, Leurs CE, Dekker I, Rispens T, Lissenberg-Witte BI, van Munster CEP, de Jong BA, van Oosten BW, Uitdehaag BMJ, Wattjes MP, Killestein J. Disease activity following pregnancy-related discontinuation of natalizumab in MS. Neurol Neuroimmunol Neuroinflamm. 2017 Dec 05;5(1):e424. doi: 10.1212/NXI.0000000000000424. eCollection 2018 Jan. PMID: 29379823; PMCID: PMC5778770.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries